Artigo Acesso aberto Revisado por pares

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

2020; Massachusetts Medical Society; Volume: 383; Issue: 21 Linguagem: Inglês

10.1056/nejmoa2022926

ISSN

1533-4406

Autores

Peter Horby, Marion Mafham, Louise Linsell, Jennifer Bell, Natalie Staplin, Jonathan Emberson, Martin Wiselka, Andrew Ustianowski, Einas Elmahi, Benjamin Prudon, Tony Whitehouse, Timothy Felton, John Williams, Jakki Faccenda, Jonathan Underwood, J. Kenneth Baillie, Lucy C. Chappell, Saul N. Faust, Thomas Jaki, Katie Jeffery, Wei Shen Lim, Alan Montgomery, Kathryn Rowan, Joel Tärning, James A Watson, Nicholas J White, Edmund Juszczak, Richard Haynes, Martin Landray,

Tópico(s)

Long-Term Effects of COVID-19

Resumo

Hydroxychloroquine and chloroquine have been proposed as treatments for coronavirus disease 2019 (Covid-19) on the basis of in vitro activity and data from uncontrolled studies and small, randomized trials.

Referência(s)